SANGAMO THERAPEUTICS Trademark

Trademark Overview

On Monday, December 28, 2020, a trademark application was filed for SANGAMO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SANGAMO THERAPEUTICS trademark a serial number of 90420110. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Saturday, March 1, 2025. This trademark is owned by Sangamo Therapeutics, Inc.. The SANGAMO THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:

Licensing of intellectual property rights

Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
sangamo therapeutics

General Information

Serial Number90420110
Word MarkSANGAMO THERAPEUTICS
Filing DateMonday, December 28, 2020
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateSaturday, March 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements

Description of MarkThe mark consists of the wording "SANGAMO" in a stylized font with the letter "O" in "SANGAMO" comprised of two concentric circles with the outer circle being broken by two diagonal lines and the word "THERAPEUTICS" in a stylized font is centered below the letters "AMO" in the wording "SANGAMO".
Goods and ServicesLicensing of intellectual property rights
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 17, 2021
Primary Code042
First Use Anywhere DateWednesday, May 31, 2017
First Use In Commerce DateWednesday, May 31, 2017
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 17, 2021
Primary Code045
First Use Anywhere DateWednesday, May 31, 2017
First Use In Commerce DateWednesday, May 31, 2017

Trademark Owner History

Party NameSangamo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRichmond, CA 94804
Party NameSangamo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30309

Trademark Events

Event DateEvent Description
Thursday, December 31, 2020NEW APPLICATION ENTERED
Wednesday, March 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 30, 2021NON-FINAL ACTION WRITTEN
Thursday, March 18, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 24, 2021ASSIGNED TO EXAMINER
Wednesday, June 30, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 30, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 22, 2022FAX RECEIVED
Monday, August 22, 2022SOU EXTENSION 1 FILED
Monday, August 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 15, 2022ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Monday, September 19, 2022RESPONSE TO ITU OFFICE ACTION ENTERED
Thursday, September 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 21, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 20, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 20, 2023SOU EXTENSION 2 GRANTED
Monday, February 20, 2023SOU EXTENSION 2 FILED
Wednesday, February 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 18, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 18, 2023SOU EXTENSION 3 FILED
Friday, August 18, 2023SOU EXTENSION 3 GRANTED
Tuesday, August 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 22, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 22, 2024SOU EXTENSION 4 FILED
Thursday, February 22, 2024SOU EXTENSION 4 GRANTED
Friday, February 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 24, 2025USE AMENDMENT FILED
Monday, February 24, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, March 1, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, August 9, 2024SOU EXTENSION 5 GRANTED
Friday, August 9, 2024SOU EXTENSION 5 FILED

Related Keywords

therapeutics sangamo research gene product others engineered scientific development medical proteins nucleic